The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
V | Various | |
2
|
V03 | All other therapeutic products | |
3
|
V03A | All other therapeutic products | |
4
|
V03AB | Antidotes | |
5
|
V03AB15 | Naloxone |
| Active Ingredient |
|---|
|
Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine. |
| Document | Type | Information Source | |
|---|---|---|---|
| NARCAN NALOXONE HCI | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| NYXOID Nasal spray | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| PRENOXAD Solution for injection/infusion | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| SUBOXONE Sublingual tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| VENTIZOLVE Nasal spray, solution | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.